Jeffrey A. Frelinger, PhD


Internal Contact Information

UACC Organizational Unit: 
Professional Bio: 

Dr. Frelinger's career has been focused on the production of antigen specific T-cells. While much of this has been directed at virus and bacterial antigens, he has used approaches to directly inform immunotherapy in cancer. Dr. Frelinger published a series of papers that follow the development of the concept of an altered peptide ligand from an observation in HIV through its confirmation with the breast tumor epitope Her2/neu into humanized ice and then into a clinical trial. He has been and continues to be interested in moving basic science from the fundamental to the practical.

Research Information

Research Program: 
Cancer Biology
Member Status: 
Research Member
Year of Membership Acceptance: 
Selected Publications: